Showing results (11-20 of 102) with videos related to
Sort By:
Pageof 11
Expert Opinion on Drug Metabolism & Toxicology|February 6, 2008
Irregular gastrointestinal drug absorption in Parkinson's diseaseDag Nyholm, Hans LennernäsBrain and Behavior|October 7, 2020
A survey of lifestyle factors in dystoniaJacob Söderlund, Dag NyholmUpsala Journal of Medical Sciences|March 10, 2017
Development of new levodopa treatment strategies in Parkinson's disease-from bedside to bench to bedsideSten-Magnus Aquilonius, Dag NyholmTherapeutic Advances in Neurological Disorders|July 5, 2022
Levodopa-entacapone-carbidopa intestinal gel infusion in advanced Parkinson's disease: real-world experience and practical guidanceDag Nyholm, Wolfgang H JostClinical Neuropharmacology|December 17, 2004
Levodopa infusion therapy in Parkinson disease: state of the art in 2004Dag Nyholm, Sten-Magnus AquiloniusJournal of Parkinson'S Disease|November 9, 2020
Effects of Helicobacter pylori on Levodopa PharmacokineticsDag Nyholm, Per M HellströmParkinsonism & Related Disorders|February 14, 2013
Spiral drawing during self-rated dyskinesia is more impaired than during self-rated OffMevludin Memedi, Jerker Westin, Dag NyholmCNS Drugs|May 4, 2016
Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic ReviewKarin Wirdefeldt, Per Odin, Dag NyholmNeurology and Therapy|March 21, 2025
Therapies for Advanced Parkinson's Disease in Sweden: A Cost-Effectiveness Analysis Using Real-World DataDag Nyholm, Simon Eggington, Astrid HolmPageof 11